Onderneming Sorrento Therapeutics, Inc.
Aandelen
SRNE
US83587F2020
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0137 USD | -31,50% | -31,50% | -88,91% |
15/03 | Scilex schikt vorderingen in zaak tegen Virpax voor $6 miljoen, 6% royalty's van drie geneesmiddelen | MT |
11/03 | Motie tot verwerping van de zaak afgewezen voor Sorrento Therapeutics, Inc. | CI |
Vakgebied
Aantal werknemers: 949
Verkoop per activiteit
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Scilex
60,5
%
| 29 | 54,0 % | 38 | 60,5 % | +33,24% |
Sorrento Therapeutics
39,5
%
| 24 | 46,0 % | 25 | 39,5 % | +1,84% |
Verkoop per regio
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 53 | 100,0 % | 63 | 100,0 % | +18,78% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 59 | 01-01-89 |
Shawn Sahebi
COO | Chief Operating Officer | - | - |
Mike A. Royal
CTO | Chief Tech/Sci/R&D Officer | 70 | 03-03-14 |
Director/Board Member | 60 | 01-10-17 | |
Jaisim Shah
BRD | Director/Board Member | 63 | 11-09-13 |
Brian Cooley
IRC | Investor Relations Contact | - | - |
William Farley
SAM | Sales & Marketing | 68 | - |
Alexis Nahama
PRN | Corporate Officer/Principal | - | 01-02-17 |
General Counsel | - | 01-01-17 | |
Mohsin Meghji
PRN | Corporate Officer/Principal | 60 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kim D. Janda
BRD | Director/Board Member | 67 | 01-04-12 |
David Lemus
BRD | Director/Board Member | 61 | 01-10-17 |
Jaisim Shah
BRD | Director/Board Member | 63 | 11-09-13 |
Yue Wu
BRD | Director/Board Member | 62 | 01-08-16 |
Henry Ji
CEO | Chief Executive Officer | 59 | 01-01-89 |
Director/Board Member | 60 | 01-10-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 558 849 336 | 546 375 093 ( 97,77 %) | 7 568 182 ( 1,354 %) | 97,77 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
SCILEX HOLDING COMPANY 1.15% | 1 917 210 | 1.15% | 3 048 364 $ |
CELULARITY INC. 2.32% | 505 043 | 2.32% | 2 641 375 $ |
Bedrijfsgegevens
Sorrento Therapeutics, Inc.
4955 Directors Place
92121, San Diego
+858 203 4100
http://sorrentotherapeutics.comSector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
-88,91% | 7,45 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers SRNE
- Onderneming Sorrento Therapeutics, Inc.